VERAXA Biotech AG (NASDAQ: VRXA; “VERAXA”), an emerging leader in designing novel cancer therapies, today announced the initiation of cell line development for ...
Sierra Nevada Corp.’s Dayton footprint has expanded rapidly since 2023, but a company leader say the biggest challenge isn’t ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する